Shanghai Allist Pharmaceuticals (SHA:688578) posted first-half attributable net profit of 1.54 billion yuan, up 47% from 1.05 billion yuan the previous year.
Earnings per share rose to 3.42 yuan from 2.34 yuan, according to Thursday filings with the Shanghai bourse.
Operating revenue climbed 40% year over year to 3.32 billion yuan from 2.37 billion yuan.
The drug manufacturer declared an interim dividend of 6.00 yuan per 10 shares.
Shares of the company rose 2% in recent trade.